Hematological Oncology (Electronic)

Publisher： John Wiley & Sons Inc

Founded in： 1996

Total resources： 17

E-ISSN： 1099-1069

ISSN： 0278-0232

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Hematological Oncology (Electronic)

Menu

Mean platelet volume predicts prognosis in patients with diffuse large B‐cell lymphoma

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 104-109

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 116-120

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 357-359

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 349-354

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Partial deletion of the ALK gene in ALK‐positive anaplastic large cell lymphoma

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 150-158

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Smoking and subsequent risk of acute myeloid leukaemia: A pooled analysis of 9 cohort studies in Japan

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 262-268

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Ibrutinib‐induced rapid response in chemotherapy‐refractory Richter's syndrome

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 370-371

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Combination of rituximab and nonpegylated liposomal doxorubicin (R‐NPLD) as front‐line therapy for aggressive non‐Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single‐center retrospective study

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 44-48

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Spectrum and immunophenotyping of 653 patients with B‐cell chronic lymphoproliferative disorders in China: A single‐centre analysis

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 121-127

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice

Hematological Oncology (Electronic) , Vol. 36, Iss. 1, 2018-02 , pp. 210-216

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 5 ... 13 Next Display item(s) per page Total 122 item(s)